ѻý

Dementia and Estrogen; Case Report on Fatality After Lecanemab; MRI-Based Brain Age

<ѻý class="mpt-content-deck">— News and commentary from the world of neurology and neuroscience
MedpageToday
Neuro Break over a computer rendering of neurons.

A nested case-control study showed that estrogen-only use in women was compared with no estrogen use. (JAMA)

Folate or was tied to a higher risk of Alzheimer's disease and changes in brain structure, but the effects were counteracted when other B vitamins were added. (The Journals of Gerontology: Series A)

Nature Communications reported the case of fatal iatrogenic cerebral beta-amyloid-related inflammation in a 79-year-old woman (Leqembi) for early Alzheimer's in the open-label extension of the CLARITY-AD trial.

Repeated blows to the head in sports or combat were identified as a potential new disease. (npj Parkinson's disease)

MRI-based brain age which patients with amyloid-negative amnestic mild cognitive impairment will convert to dementia. (Scientific Reports)

CDC data showed a gradual increase in over the past decade, with the greatest increase in people age 75 and older. (JAMA Neurology)

The Pittsburgh Post-Gazette revisited the as "type 3 diabetes."

Artificial intelligence effectively using retinal photographs. (JAMA Network Open)

An augmented reality app from otherwise healthy people who had Alzheimer's pathology. (npj Digital Medicine)

A woman with brain fog and other long COVID symptoms. (New York Times)

Are we ready for the insurance consequences of testing? (JAMA Neurology)

  • Judy George covers neurology and neuroscience news for ѻý, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.